Minnesota’s attorney general says that Surmodics’ plan to get acquired by a Chicago-based private equity firm is “anticompetitive.”
Health Care + Med Tech
The Dutch multinational giant says it will hire about 150 people locally as a result of the expansion.
This Arden Hills startup is reimagining X-ray protection for medical staff.
The concept has expanded significantly in recent years, three panelists said at a TCB Talks panel discussion at the Minneapolis Club on Thursday.
Cleo Skin and Laser is moving the needle in tattoo removal, making the service feel luxurious (and less painful).
The university and Fairview welcomed the attorney general’s intervention amid an impasse over a new partnership with Duluth-based Essentia.
State research shows parts of Minnesota that have either low or limited pharmacy access.
The Rochester-based nonprofit health system’s operating income hit nearly $1.3 billion in 2024.
Long heralded as a balm for America's troubled health care system, outcome-based insurer reimbursement has yet to find its foothold.
As part of a "transformation plan,” the Minnesota company says it will sell the business unit to Massachusetts-based Thermo Fisher Scientific Inc.
The former U.S. Bancorp executive chair and CEO was elected to a four-year term.
Negotiators for the U of M and Essentia need to recognize the leverage that Fairview holds.
Maple Grove-based Morari will soon begin a phased commercial rollout of its product to delay ejaculation in men.
But, in a letter to employees, CEO James Hereford expressed openness to a new partnership, while the U of M publicly discloses merger proposal details.
Mental health is profoundly important in professional life — and for future innovators. By supporting initiatives that address mental health and substance use challenges early on, businesses can create a culture of wellness in the workplace (and in everyday life). This is an opportunity to strengthen Minnesota's workforce by empowering young people to gain healthy habits and lead fulfilling professional and personal lives.
Keith Ellison said Monday his office has reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a month.
The proposed framework leaves big questions about the university's existing relationship with Fairview Health Services.
The Maple Grove-based company plans to use the money to fund a clinical trial and to hire more employees.